TITLE

LDL stimulates mesangial flbronectin production and chemoattractant expression

AUTHOR(S)
Rovin, Brad H.; Tan, Laura C.
PUB. DATE
January 1993
SOURCE
Kidney International;Jan1993, Vol. 43 Issue 1, p218
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Hyperlipidemia has been associated with glomerulosclerosis and a glomerular monocyte infiltrate in models of progressive renal insufficiency. The pathogenesis of hyperlipidemia-induced renal injury remains unknown. We postulated that the effect of hyperlipidemia may be mediated through LDL-induced activation of mesangial cells, which have recently been shown to possess LDL receptors. To test this hypothesis, cultured human mesangial cells were co-incubated with human LDL. Monolayers treated with LDL demonstrated a greater level of tissue culture supernatant fibronectin than control mesangial cells. This correlated with enhanced expression of fibronectin mRNA in LDL-treated mesangial cells. Additionally, LDL conditioning of mesangial cells caused a dose- and time-dependent increase in the expression of monocyte chemoattractant protein-1 mRNA, a monocyte specific chemotactic factor, as well as an increase in the monocyte chemotactic activity of mesangial supernatants. Thus, the deleterious effects of hyperlipidemia on the kidney may be mediated by the mesangial cell through an increase in production of mesangial matrix and recruitment of inflammatory cells to the glomerulus.
ACCESSION #
14906430

 

Related Articles

  • Treatment of hyperlipidemia reduces giomerular injury in obese Zucker rats. Kasiske, Bertram L.; O'Donnell, Michael P.; Cleary, Margot P.; Keane, William F. // Kidney International;Mar1988, Vol. 33 Issue 3, p667 

    Hyperlipidemic obese Zucker rats develop albuminuria and spontaneous focal glomerulosclerosis (FGS) at an early age, despite normal glomerular capillary pressures and nephron plasma flows. To investigate the role of abnormal lipid metabolism In the pathogenesis of FGS, pharmacologic agents were...

  • Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients. D'Amico, Giuseppe; Gentille, Maria Gabriella // Kidney International Supplement;Apr1991, Issue 31, pS-65 

    Presents a study on the pharmacological and dietary treatment of lipid abnormalities in nephromatic patients. Description on the abnormalities of lipid metabolism in nephromatic patients and their possible underlying pathogenetic mechanisms; Consideration of dietary manipulation as the most...

  • Hyperlipidemia of the nephrotic syndrome. Kaysen, George A. // Kidney International Supplement;Apr1991, Issue 31, pS-8 

    Presents a study which sought to examine nephrotic syndrome characterized by hyperlipidemia. Discussion on the plasma lipoprotein composition in the nephrotic syndrome; Increase in the synthesis of lipid in the nephrotic syndrome; Assessment on the effect of altered glomerular permselectivity on...

  • Anti-inflammatory lymphokine mRNA expression in antibody-induced glomerulonephritis. Lakkis, Fadi G.; Baddoura, Fady K.; Cruet, Eddie N.; Parekh, Kannan R.; Fukunaga, Megumu; Munger, Karen A. // Kidney International;Jan1996, Vol. 49 Issue 1, p117 

    T helper subset 2 (Th2) lymphocytes produce interleukin 4 (IL-4) and IL-10, which exert anti-inflammatory actions on monocytes and macrophages. Th1 lymphocytes, on the other hand, secrete interferon-γ (IFNγ) which promotes tissue inflammation. The functional dichotomy between Th1 and Th2...

  • Incidence of biopsy-proven glomerulonephritis. Ole Wirta; Jukka Mustonen; Heikki Helin; Amos Pasternack // Nephrology Dialysis Transplantation;Jan2008, Vol. 23 Issue 1, p193 

    Background. The reported biopsy-proven glomerulonephritis incidence varies according to population characteristics, the unknown true glomerulonephritis incidence and biopsy rate. Reported glomerulonephritis incidence should be evaluated against the biopsy rate. Methods. We report here the...

  • Natural history and treatment of primary proliferative glomerulonephritis: A review. Glassock, Richard J. // Kidney International Supplement;Dec1985, Issue 17, pS136 

    Discussed the aspects of the natural history and treatment of primary proliferative glomerulonephritis. Classification of proliferative glomerulonephritis; Association of severe hypertension with the development of focal and segmental glomerulosclerosis and diffuse interstitial fibrosis;...

  • The relation between methods and recommendations in clinical practice guidelines for hypertension and hyperlipidemia. Fretheim, Atle; Williams Jr., John W.; Oxman, Andrew D.; Herrin, Jeph // Journal of Family Practice;Nov2002, Vol. 51 Issue 11, p963 

    OBJECTIVE To assess the association between methods used to develop clinical practice guidelines and the recommendations that are made. STUDY DESIGN Systematic review of clinical practice guidelines for hypertension or hyperlipidemia. OUTCOMES MEASURED Two people independently appraised...

  • Lack of Association Between Carotid Intima-Media Thickness and PAF-Acetylhydrolase Mass and Activity in Patients with Primary Hyperlipidemia. Kiortsis, Dimitrios N.; Tsouli, Sofia; Lourida, Evangelia S.; Xydis, Vasilios; Argyropoulou, Maria I.; Elisaf, Moses; Tselepis, Alexandros D. // Angiology;Jul/Aug2005, Vol. 56 Issue 4, p451 

    Carotid intima media thickness (IMT), represents an important clinical indicator of early atherosclerosis. Human plasma platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme primarily associated with low-density lipoprotein (LDL) while a small proportion of enzymatic activity is also...

  • Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors. Dehghani, Seyed Mohsen; Taghavi, Seyed Ali Reza; Eshraghian, Ahad; Gholami, Siavash; Imanieh, Mohammad Hadi; Bordbar, Mohammad Reza; Malek-Hosseini, Seyed Ali // Journal of Gastroenterology;Sep2007, Vol. 42 Issue 9, p769 

    Hyperlipidemia is a metabolic complication after liver transplantation (LT). The aim of this study was to investigate the prevalence and risk factors for developing hyperlipidemia in patients who underwent LT in the Shiraz Organ Transplantation Center. Our patients were 170 liver recipients who...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics